One of the most appropriate biomarkers for the verification of organophosphorus nerve agent exposure is the conjugate of the nerve agent to butyrylcholinesterase (BuChE). The phosphyl moiety of the nerve agent can be released from the BuChE enzyme by incubation with fluoride ions, after which the resulting organophosphonofluoridate can be analyzed with gas chromatography-mass spectrometry (GC-MS). This paper describes recent improvements of the fluoride-induced reactivation in human plasma or serum samples by enhancing the sample preparation with new solid-phase extraction cartridges and the MS analysis with large volume injections. Analysis is performed with thermal desorption GC with either mass selective detection with ammonia chemical ionization or high-resolution MS with electron impact ionization. The organophosphorus chemical warfare agents analyzed in this study are O-ethyl S-2-diisopropylaminoethyl methylphosphonothiolate, ethyl methylphosphonofluoridate, isopropyl methylphosphonofluoridate (satin, GB), O-ethyl N,Ndimethylphosphoramidocyanidate, ethyl N,N-dimethylphosphoramidofluoridate, and cyclohexyl methylphosphonfluoridate. Detection limits of approximately 10 pg/mL plasma were achieved for all analytes, which corresponds to 0.09% inhibition with GB on a sample with normal BuChE levels.
Introduction
As long as there exists a threat of exposure to nerve agents (NA), methodologies for retrospective biomonitoring of exposure to these kinds of agents are needed. Reliable and sensitive detection methods are required to verify suspected exposures to chemical warfare agents (CWA) for several reasons. From the military-political point of view, it is desirable to establish and monitor possible casualties on the battlefield or during peacekeeping operations. Also, methods are needed for possible ~ Author to whom correspondence should be addressed.
health surveillance programs for employees working in CWA destruction facilities. Furthermore, the Organization for the Prohibition of Chemical Weapons (OPCW) has addressed the issue of whether biological samples taken during their inspections should be screened for CWAs. In the case of a terrorist assault, unambiguous verification of CWA exposure is essential, as this information can be used as forensic evidence, in the treatment of casualties, or to suggest the need for long-term monitoring for possible adverse health effects.
Qualifications for longer-lived biomarkers suited for verification of exposure to CWA are that they should be specific for the agent, detectable at low concentrations, and persist in the body for a significant time period following exposure, allowing ample time for sample collection. Exposure to organophosphorus nerve agents (OPNA) results in the rapid formation of a covalent bond between the phosphyl moiety of the agent and the serine active site of cholinesterase in whole blood. The NAleaving groups in this reaction are either fluoride ion [isopropyl methylphosphonofluoridate (satin, GB) and cyclohexyl methylphosponfluoridate (cyclohexylsarin, GF)], a cyano group [O-ethyl N,N-dimethylphosphoramidocyanidate (tabun, GA)], or a thiol group [O-ethyl S-2-diisopropylaminoethyl methylphosphonothiolate (VX)]. Presuming no hydrolysis or aging of the various alkyl ester groups once the adduct is formed, each resulting conjugate is a distinct marker for the specific inhibiting agent. For the sake of completeness, it should be noted that at higher levels (0.01-400 IJg/mL plasma), NAs also bind to other serum proteins like serum albumin (1) .
The binding of OPNAs effectively inhibits the function of the cholinesterase. The extreme toxicity of nerve agents is due to the inhibition of acetylcholinesterase (ACHE), which leads to the buildup of acetylcholine in cholinergic synapses. Butyrylcholinesterase (BuChE) is also bound by the nerve agent at an active serine residue and is found at high concentrations (average 80nM) in human serum and plasma versus trace concentrations of AChE found in erythrocytes (2, 3) . OPNA-BuChE adducts, therefore, offer an attractive alternative to AChE adducts, as they are abundant in serum and plasma. Analysis of OPNA-BuChE adducts with the improved fluoride method described here has led to detection limits corresponding to less than 1% inhibition by each agent.
The final requirement for longer-lived biomarkers to OPNA exposure is biological persistence, which is a significant advantage of adduct analysis over urinary metabolite analysis. Based on a study in which atropinized rhesus monkeys were exposed to GB and GA at levels yielding an initial 40% inhibition of BuChE, the OPNA-BuChE adduct as analyzed by the fluoride regeneration method was detectable at inhibition levels down to 0.01% up to 35 days following exposure (4) . In contrast, urinary metabolites were generally excreted within 2-3 days (5).
Several analytical approaches that exploit NA adducts on cholinesterases (either butyryl or acetyl) for verification of exposure to NAs have been described. Nagao et al. (6) and Matsuda (7) published the analysis of inhibited ACHE, followed by trypsinization, alkaline phosphatase treatment, derivatization of the released alkylmethylphosphonic acid, and analysis with gas chromatography-mass spectrometry (GC-MS). Fidder et al. (8) described the isolation of BuChE from plasma, followed by digestion with pepsin and analysis with liquid chromatography (LC)-MS--MS of the peptide conjugated with the NA adduct. Both methods are rather laborious. Polhuijs et al. (9) NA-inhibited BuChE with fluoride ions. Upon incubation with fluoride, the phosphyl moiety of the nerve agent is released from the enzyme, resulting in generation of either the original agent (GB and GF) or a fluoro derivative of the agent (VX and GA). Figure 1 depicts the structures and inhibitory mechanism of OPNA, along with the concepts of regeneration and aging. Once the adduct has aged, it no longer lends itself to fluoride release or cholinesterase reactivation with agents such as oximes. The released agents can be analyzed with GC directly after solid-phase extraction (SPE). The rather simple sample preparation and low detection limits of the NA that can be obtained with the sensitive GC separation and MS detection techniques make this method one of the most powerful for the verification of exposure to NAs. This paper describes improvements of the fluoride reactivation method by using a new SPE technique with large volume sample injection on either a GC-quadrupole-MS or a GC-high-resolution MS (HRMS) using a magnetic sector MS. This method is simpler and more sensitive than the previously published methods for detection and quantitation of OPNA-BuChE adducts. The previous method (9) used a C]8 silica-based SPE and analysis with GC using on-column injection and alkali flame detection. The slow speed at which the samples pass through the silicabased columns and the fact that they must not go dry during the procedure severely limited their usefulness in routine application of the method. In order to facilitate the extraction, we evaluated the performance of a highly crosslinked poly(styrene/methacrylate)-copolymer based SPE cartridge. In addition, variability of the improved method was established for each agent. Experiments were performed at two different laboratories with two different types of instrumentation: TNO-Prins Maurits Laboratory (TNO-PML) in Rijswijk, The Netherlands used GC-MS, and the Centers for Disease Control and Prevention (CDC) in Atlanta, GA used GC-HRMS.
Experimental

Materials
The native agents GB (sarin), GA (tabun), GF (cyclohexylsatin), and VX were obtained from the stocks of TNO-PML Labeled standards, sarin-cd3, ethylsarin-cd3, cyclohexylsarin-cd3, sarin-c3dT, ethylsarin-czd5, and fluorotabun-c2ds, were synthesized according to Benschop Nexus TM SPE-cartridges (200 rag, 6 mL) were obtained from Chrompack (Varian, Inc., Palo Alto, CA). Ethyl acetate, nhexane, sodium bicarbonate, potassium fluoride, acetic acid, and sodium acetate were purchased from Merck (Darmstadt, Germany) or Aldrich (Milwaukee, WI). Tenax-TA (60-80 mesh) was acquired from Alltech (Deerfield, IL) or Gerstel (Baltimore, MD). DMCS-treated glass wool was also obtained from Alltech.
Cholinesterase activity
All cholinesterase activity levels were determined by TNO-PML using the Ellman method (11) and CDC using the TestMate ChE Cholinesterase Test System from EQM Research, Inc. (Cincinnati, OH). Daily control samples from Roche Diagnostics (F. Hoffmann-La Roche, Ltd., Diagnostics Division, Basel, Switzerland) were run to monitor the performance of the cholinesterase test system. Serum BuChE levels prior to NA addition were within the normal range of 1.35-3.23 U/mL, based on whole blood levels, as specified by EQM Research, Inc. Serum BuChE levels were not depressed by addition of stock solution solvent only (acetonitrile or 2-propanol). In order to ensure that false positives were not detected as a result of overdose of NA (i.e., spiking with more NA than required for 100% inhibition), serum samples inhibited to 100% were prepared according to protocol, except for refluoridation, and analyzed for presence of excess nerve agent.
Fluoride reactivation
Human plasma samples (1 mL) were mixed with 3 mL acetate buffer (0.189M acetic acid and 10.8mM sodium acetate, pH 3.5) and 190 IJL potassium fluoride (5.25M), resulting in a final concentration of 0.25M KF. After incubation for 15 rain at 25~ the mixture was neutralized with 0.5 mL 0.8M sodium bicarbonate solution; this was done because prior experiments revealed that traces of acetic acid disturbed the GC analyses of large-volume injections of NA. The appropriate internal standard was then added, and the organophosphonofluoridates were extracted using SPE.
SPE
Nexus cartridges were conditioned by consecutive rinsing with 4 mL n-hexane, 2 x 4 mL ethyl acetate, and 2 x 5 mL water. Each solvent was gently pushed dropwise through the cartridge until the cartridge was dry. The sample was then applied to the cartridge, and the organophosphonofluoridates were eluted with 2 mL ethyl acetate. The ethyl acetate eluate was collected in a centrifuge tube and cooled in dry ice/acetone (-80~ to freeze the water. The ethyl acetate upper layer was then transferred to a GC vial by Pasteur pipette. All extracts were analyzed using one of the analysis techniques to be described here.
Instrumental analysis
GC-HRMS analysis. Samples were analyzed on a Finnigan
Mat 900 XL double focusing magnetic sector MS interfaced to an HP 6890 GC. Ionization was accomplished in electron impact (EI) ionization mode. The ion calibration gas was FC-53, and the lock mass used for each analyte was 118.9920. Resolution was set to 4000 (established at 10% valley) for the analyses, and injection volumes were 100 IJL. Maximum sensitivity, however, could be obtained with 10,000 resolution and 200 pL injections. The outer source of the MS was maintained at 250~
Sample loading was performed using the Gerstel thermal desorption system (TDS) and Gerstel cooled injection system (CIS) (Gerstel GmbH, MCilheim an der Ruhr, Germany). Samples were loaded onto Tenax TA 7-in. thermal desorption tubes using a Gerstel tube spiking apparatus with a constant helium flow of 80 mL/min and heat block temperature of 80-85~ a few degrees above the boiling point of the ethyl acetate solvent. Tenax tubes were conditioned at 300~ for 1 h prior to each use. Settings for TDS were as follows: initial temperature of 20~ ramped to 260~ at 60~ and held for 5 min; splitless flow mode; and transfer line temperature, 280~ The liner was a Gerstel CIS 4, 3-mm outer diameter, and completely filled with silanized glass wool. CIS settings were as follows: initial temperature of -100~ ramped to 300~ at 12~ and held for 3 min. The CIS portion of the injections were done in solvent vent mode with a vent flow of 70 mL/min, purge time of 1 min, purge flow of 50 mL/min, and vent pressure of 19 psi. The CIS used cryocooling with liquid N2 to obtain relatively quick equilibration at -100~ between samples.
The GC column was a 60-m DB5-MS column with a 0.25-ram internal diameter and 0.25-1Jm film thickness (J&W Scientific, Folsom, CA). Helium carrier was maintained at a constant flow of 1.0 mL/min, and the transfer line was set at 250~ the GC program began at 75~ for 30 s, ramped to 150~ at 5~ then ramped to 310~ at 50~
where it was held for 2 rain. The final ramp was intended to clean the column prior to the next injection. The total GC run time was 20.7 rain. Table I contains the masses for the native and labeled ions monitored for each NA, along with their average retention times.
GC-MS analysis. Analyses were performed on an Agilent
6890A GC, equipped with a Gerstel thermo desorption autosampler device (TDSA), and an Agilent 5973 mass selective detector (MSD) (Agilent Technologies, Inc., Wilmington, DE). The GC was fitted with a 30-m x 0.25-ram i.d. fused-silica column coated with CP-Sil 19 C and a 1.00-1Jm film thickness (Chrompack, Varian) inserted directly into the MS source. The desorption tubes for the TDSA were filled with 300 mg Tenax TA (60-80 mesh) and a loosety packed plug of dimethyldichlorosilane-treated glass wool of approximately 3-4 cm to promote evaporation of the large volume of ethyl acetate solvent. Before use, the Tenax tubes were rinsed with 5 mL ethyl acetate and preconditioned by heating under a stream of helium or nitrogen at 220~ for 8 h. Tenax tubes were loaded with 100-400 IJL of the ethyl acetate extracts in portions of 100 IJL using a Hamilton 100-1JL syringe with a loading interval time of 5 min. During this step, a gentle stream of nitrogen (250 mL/min) flowed through the tubes to evaporate the ethyl acetate solvent. Fifteen minutes after the final loading step, the Tenax tube was installed into the TDSA. The TDSA oven temperature was started at 30~ and then ramped at 60~ to 220~ where it was held for 5 min. During desorption, the helium flow rate through the tube was 30 mL/min. The TDSA-GC transfer line was set at 220~
The desorbed sample components were trapped in splitless mode by a CIS, which was cooled to -50~ with liquid nitrogen. After desorption, the trapped components were transferred in splitless mode to the capillary column by rapid heating of the CIS at 12~ to 220~ where it was held for 5 min. The splitless time was 1 rain, and the purge flow was 50 mL/min. The initial GC oven temperature was 65~ for 4 min, then ramped at 20~ to 260~ and held at this temperature for 11 rain. The column flow during analysis was set at I mL/min in constant flow mode. The transfer line was heated at 220~ The MSD was operated in the selected ion mode (SIM) using positive ion chemical ionization (CI) with ammonia as reagent gas and an SIM dwell time of 80 ms. The temperature of the quadrupole was maintained at 130~ and the temperature of the ionization source was 160~ Table I shows the ions monitored [M+NH4] § and the retention times.
Serum inhibition for calibration, quantitation, and precision
Human plasma was partly inhibited with satin or VX by incubation with the particular agent for 60 min at room temperature. Residual BuChE was measured according to the Ellman method (11) . It appeared that after incubation with sarin (final concentration 5.5 ng sarin/mL plasma), BuChE inhibition was 21%. After incubation with VX (final concentration 10 ng VX/mL plasma), BuChE inhibition was 60%. The BuChE activity of blank plasma was 2.8 U/mL, which corresponds with approximately 46nM (12) . The inhibited plasma was further diluted with uninhibited plasma to obtain levels 0.05%, 0.1%, 0.2%, 0.5%, 1%, and 10% of BuChE inhibition. Aliquots of 1 mL plasma were incubated with fluoride ions and further processed as described vide supra. Quantitation of the regenerated amounts of ethylsarin and sarin was based on known quantities of the labeled internal standards that had been added, using the ratio of the peak area of EtSa/EtSa-d5 and sarin/sarin-d7, respectively.
An alternative scheme for calibration of the method involved addition of native and labeled standards to uninhibited serum after incubation with fluoride ions, followed by extraction and analysis according to protocol. The concentration of natives in the calibration standards ranged from 27.5 pg/mL to 2.2 ng/mL (corresponding to a theoretical 0.25-20% inhibition by GB); the concentration of labeled internal standards was held constant at 2.2 ng/mL. Quantitation performed against curves created in this manner yielded absolute picogram values of regenerated agent as an alternative to the percentage of the victim's BuChE that is inhibited relative to the calibrator serum pool.
Serum pools for examination of method precision were created by first spiking blank human serum with NA to reach 100% BuChE inhibition, as verified by the Test-Mate EQM cholinesterase testing system. Prior to inactivation, serum BuChE activity levels were considered clinically normal and ranged from 2.11 to 2.55 U/mL. Following agent addition, no BuChE activity was detected. It was confirmed that any excess agent had hydrolyzed by processing and analyzing 1 mL 100% inhibited serum without incubation with KF. This pool was then diluted to 10% inhibition with blank serum, and 1-mL aliquots were processed according to protocol.
Results
SPE
Although the supplier of the Nexus cartridge claims that these cartridges can be used without any preconditioning steps, experiments showed that a preconditioning of the cartridges is necessary. Analysis of an ethyl acetate (2 mL) rinse of a nonconditioned SPE cartridge showed a high background, with interfering peaks at the masses measured for target analytes. Figure 2A shows rinse. The baseline is heavily disturbed and shows interfering signals at the same retention time as sarin. However, no interfering peaks were observed after performing the same analysis on an SPE column preconditioned according to our method ( Figure 2B ). Figure 3A shows the MSD chromatogram of a calibration plasma sample, close to the limit of detection (LOD), in which 0.05% of BuChE was inhibited with sarin. A chromatogram of the control (blank) plasma sample showed no interfering signal, as can be seen in Figure 3B . Figure 4A shows the amount of sarin detected by MSD that could be regenerated as function of the degree of BuChE inhibition. The linear regression curve shows that extrapolation to 100% inhibition would yield 57nM satin, which is in reasonable agreement with the concentration of BuChE in plasma.
Calibration and quantitation
Similar results were obtained with VX. Ethylsarin could be detected after fluoride reactivation in a sample containing 0.1% inhibited BuChE. Figure 4B shows the amount of ethylsarin detected by the MSD that could be regenerated as a function of BuChE inhibition by VX. Extrapolation of the BuChE inhibition to 100% shows that 53nM ethylsarin could be regenerated, again in reasonable agreement with the concentration of native plasma. Figure 5 displays calibration curves created on HRMS by addition of native and labeled standards after incubation with fluoride ions. Using these curves, quantitation of fluorotabun and cyclohexylsarin regenerated from 10 10% inhibited samples yielded mean concentrations of 0.88 and 0.71 ng/mL serum, respectively. The BuChE level of the serum prior to addition of agent was 2.37 U/mL or 38.9 nm. For fluorotabun, this molarity 0f BuChE corresponds to a maximal regeneration of 6.03 ng/mL for a 100% inhibited sample or 0.603 ng/mL for a 10% inhibited sample. The maximum amount of cyclohexylsarin that could be regenerated from a sample inhibitited to 100% of 38.9 nm BuChE was 7.00 ng/mL or 0.700 ng/mL for a 10% dilution. Experimental values obtained from the calibration curves are in good agreement with the calculated quantities that were based on measured BuChE levels in the uninhibited serum.
Precision
Repeatability of the method was assessed by HRMS for each nerve agent at 10% inhibition using the prepared serum pools. Ten samples were prepared according to the method for each NAoBuChE adduct and were injected twice each. The relative standard deviations (RSDs) ranged from 2 to 13% (Table II ). An example Shewhart quality-control plot generated from these analyses is shown in Figure 6 .
Sensitivity
The sensitivity of the HRMS analysis was evaluated by regenerating agents present at very low levels of BuChE inhibition. Serum inhibited to 100% was diluted with blank serum to 0.25%, 0.20%, 0.15%, 0.10%, 0.05%, and 0.025% inhibition levels for each agent. to our method and analyzed by GC-HRMS, using a 200-1JL injection and 10,000 resolution to obtain optimal sensitivity. Regenerated satin was detectable to 0.05% BuChE inhibition, which corresponds to a concentration of approximately 6 pg/mL serum. Ethylsarin generated from fluoridated VX was detectable to 0.025% inhibited BuChE or 3 pg/mL. Cyclohexylsarin and fluorotabun were detectable to 0.15% (17 pg/mL) and 0.10% (11 pg/mL), respectively. Cyclohexylsarin and fluorotabun may have had marginally higher detectable levels because of faster aging of the adducts, thereby preventing refluoridation or higher absolute detection limits for cyclohexylsarin and fluorotabun. Analysis of uninhibited serum showed no interfering responses from blank matrix. Figure 7 shows HRMS chromatograms for the analysis of uninhibited serum and serum inhibited with VX at 0.025%, both incubated with KF. The determination of the sensitivity was based on signal-to-noise (S/N) ratio > 3. Concentration (ng/mL) Figure 5 . Plots A and B of the calibration curves based on ng/mL of tabun and cyclohexylsarin, respectively, recovered from serum. Both natives and labels were spiked after incubation with KF. 
Discussion
The fluoride reactivation technique as published by Polhuijs et al. (9) utilizing Sep-Pak C18 cartridges for SPE followed by GC analysis with on column injection and nitrogen phosphorus detection has been improved to achieve lower detectable concentrations (lower levels of BuChE inhibition). Thermal desorption from Tenax allows the introduction of larger sample volumes (up to 400 IJL), thus lowering the detectable concentration. Because an increased sample volume will also magnify matrix effects, introduction of larger volumes requires cleaner samples. Polymer-based SPE cartridges proved to be very useful for trace enrichment of nerve agents in plasma samples. Chromatograms produced with Nexus cartridges were cleaner than the chromatograms of Sep-Pak C18 extracts. Additionally, the sample preparation method reported here was easier than the previous method. Application and elution of samples with SepPak C18 cartridges required much more pressure than Nexus cartridges, and there was no loss of analyte if a Nexus cartridge runs dry during the SPE procedure. Detection of the nerve agents from the large volume thermal desorption injection GC runs could be done by either HRMS with EI or with MSD with ammonia CI; similar results were observed with both MS configurations. EI with 10,000 resolution produced very clean chromatograms on the magnetic sector MS. On the low-resolution single-quadrupole, EI could not be used because the background signal in the extracted ion chromatogram of the [CHsFO2P] + base peak at m/z 99 was too high. D'Agostino et al. (13) analyzed low level OP-CWAs using positive CI with ammonia as reagent gas. Hydrocarbons and other matrix components with relatively low proton affinities were not ionized, which resulted in lower backgrounds and more selective detection of the OP compounds, as compared to methane CI. The use of chemical ionization was also attempted on the magnetic sector but was less sensitive than EI. This is most likely because the calibrant ions used as a lock mass on the magnetic sector are very weak in the low mass range in CI mode. Very similar sensitivities were found on each instrument when using their optimal ionization mode.
LODs were calculated according to the standard method defined by Taylor (14) and the American Chemical Society (15) . According to this method, LOD = 3 x So, where So is estimated as the y-intercept of the best fit line through points on a plot of standard deviation of the responses from the five standards used in the calibration curve versus their concentrations. This calculation resulted in the following detection limits for analysis by HRMS: ethylsarin, 2.4 pg/mL (0.02%); sarin, 1.2 pg/mL (0.01%); fluorotabun, 6.3 pg/mL (0.05%), and cyclohexylsarin, 8.6 pg/mL (0.06%). These calculated concentrations for each analyte, however, were often below the actual lowest detectable 
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Journal of Analytical Toxicology, Vol. 28, July/August 2004 concentration of agent as determined in the sensitivity analysis. LODs for HRMS were, therefore, established as the minimum measurable level: ethylsarin, 3 pg/mL (0.025%); sarin, 6 pg/mL (0.05%); fluorotabun, 11 pg/mL (0.10%), and cyclohexylsarin, 17 pg/mL (0.15%). The minimum measurable levels using the GC-MSD method were 10 pg/mL for ethylsarin and 6 pg/mL for sarin. Detection limits prior to the method improvements reported here were 0.2 ng sarin/mL serum (4), which corresponds to approximately 1.8% inhibition for an individual with normal BuChE levels. This increase in sensitivity can be crucial when analyzing samples collected weeks after exposure or when monitoring low-dose, long-term exposures to nerve agents and their potential heath effects (16) . Method RSDs for all analytes were under 15%, showing good precision of the method.
Fluoride regeneration of nerve agents provides a sophisticated alternative to traditional cholinesterase testing, which requires an excess of 20% inhibition because of natural fluctuations in cholinesterase levels (17) . This fairly simple method requires less than 1% cholinesterase inhibition. Results from a study of victims from the 1995 Tokyo sarin attacks showed up to 4.1 ng sarin recovered per milliliter serum (9) . The LOD of the Tokyo sarin victim study was 0.2 ng/mL serum, which corresponds to 1.8% inhibition for a person with an 80nM average BuChE concentration. A result for 1 of the 11 victims was below 0.2 ng sarin/mL serum. The concentrations of sarin from the victims that had detectable levels of sarin-BuChE ranged from 0.2 (1.8%) to 4.1 ng/mL (37.3%), with an average value of 2.18 ng/mL (19.8%). Two of seven samples from a terrorist incident in Matsumoto analyzed tested positive for satin (9) ; the others may have had exposures that were not detectable with the LODs of the method used at that time. Figure 8 shows two chromatograms of agents regenerated from serum or plasma inhibited to 10%, in the range of a true, symptomatic exposure. Figure 8A illustrates a chromatogram of ethylsarin generated by CI-MSD, and Figure 8B displays ethylsarin as analyzed by HRMS.
The lowered detection limits achieved with the improvements reported here require an increased sample run time, which could become a limitation in an emergency response situation. The run time for CI-MSD analysis was approximately 40 rain per sample and approximately 45 min for HRMS analysis, which includes the entire cycle time needed for equilibration for the CIS, thermal desorption injection, and GC run time. Additional time was required for sample loading onto Tenax tubes; once loaded, however, samples may be conveniently stored on Tenax until desorption. Care must be taken that Tenax tubes are thoroughly conditioned before each use and stored in properly sealed containers, as the material will absorb compounds from the air which can cause background interferences.
MSD instruments are convenient to use in the laboratory because of their relatively low cost and ease of operation and maintenance compared to a high-resolution instrument. However, because the MSD has low resolution, it is possible that a false-positive signal will be obtained. If necessary for confirmation purposes, several measures can be considered if a peak is observed having the mass-to-charge ratio and retention time of an NA: (i) change the GC conditions (i.e., use a lower oven 
Conclusions
We have developed two new MS approaches and refined sample preparation to improve a rapid and sensitive method for the analysis of BuChE adducts with NAs. One advantage to this type of approach is that the analysis can be done on samples that are collected weeks after the exposure. It is also far more sensitive than traditional cholinesterase testing methods and distinguishes exposures to organophosphate or carbamate pesticides from NA exposures. Most importantly, it can identify the specific agent that is bound to BuChE.
Given the possible impact of nerve agent exposure in a forensic case or to public health, it is essential that the results of the tests are unambiguous. Using the MSD configuration, it might be necessary to perform additional analyses in order to exclude possible false-positive results. The possibility of obtaining false-positive results is smaller with the HRMS instrument. With either configuration, the improvements result in a decrease in LODs of one to two orders of magnitude.
